Forte Biosciences, Inc. (FBRX) Net income 2016–2025
Forte Biosciences, Inc. (FBRX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$69.4MFY2025 · since FY2016: -$33.5M → -$69.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$69.4M | -95.5% |
| FY2024 | -$35.5M | -12.7% |
| FY2023 | -$31.5M | -126.8% |
| FY2022 | -$13.9M | +36.1% |
| FY2021 | -$21.7M | +53.3% |
| FY2020 | -$46.5M | -1042.5% |
| FY2019 | -$4.1M | +91.7% |
| FY2018 | -$49.0M | -25.8% |
| FY2017 | -$38.9M | -16.3% |
| FY2016 | -$33.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice